Rank | Gene Set | Z-score |
---|---|---|
1 | pattern specification involved in kidney development (GO:0061004) | 9.06373366 |
2 | intestinal cholesterol absorption (GO:0030299) | 8.20185609 |
3 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 8.02668883 |
4 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 7.87764873 |
5 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 7.76447080 |
6 | thioester biosynthetic process (GO:0035384) | 7.76017591 |
7 | acyl-CoA biosynthetic process (GO:0071616) | 7.76017591 |
8 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 7.56302350 |
9 | alpha-linolenic acid metabolic process (GO:0036109) | 7.28869430 |
10 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 6.97501326 |
11 | regulation of sequestering of triglyceride (GO:0010889) | 6.89336075 |
12 | lactation (GO:0007595) | 6.82639755 |
13 | sterol catabolic process (GO:0016127) | 6.72583806 |
14 | cholesterol catabolic process (GO:0006707) | 6.72583806 |
15 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 6.62619441 |
16 | positive regulation of p38MAPK cascade (GO:1900745) | 6.44076105 |
17 | regulation of phospholipid biosynthetic process (GO:0071071) | 6.41003318 |
18 | phospholipid homeostasis (GO:0055091) | 6.35491836 |
19 | linoleic acid metabolic process (GO:0043651) | 6.19163078 |
20 | nucleoside transmembrane transport (GO:1901642) | 6.02942018 |
21 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 6.02326788 |
22 | fatty acid transmembrane transport (GO:1902001) | 5.98882386 |
23 | carnitine shuttle (GO:0006853) | 5.92925523 |
24 | mammary gland epithelial cell differentiation (GO:0060644) | 5.89707080 |
25 | secretion by tissue (GO:0032941) | 5.75666990 |
26 | fatty-acyl-CoA metabolic process (GO:0035337) | 5.74683321 |
27 | intestinal absorption (GO:0050892) | 5.73907893 |
28 | ectoderm development (GO:0007398) | 5.58953981 |
29 | biotin metabolic process (GO:0006768) | 5.56633200 |
30 | ceramide catabolic process (GO:0046514) | 5.51265774 |
31 | negative regulation of protein kinase B signaling (GO:0051898) | 5.24448143 |
32 | mitochondrial calcium ion transport (GO:0006851) | 5.07331471 |
33 | acetyl-CoA metabolic process (GO:0006084) | 5.01889216 |
34 | nucleobase catabolic process (GO:0046113) | 4.99573730 |
35 | positive regulation of osteoblast proliferation (GO:0033690) | 4.98630352 |
36 | embryonic process involved in female pregnancy (GO:0060136) | 4.91059968 |
37 | segment specification (GO:0007379) | 4.86040590 |
38 | body fluid secretion (GO:0007589) | 4.82030584 |
39 | N-acetylneuraminate metabolic process (GO:0006054) | 4.81146037 |
40 | negative regulation of endothelial cell proliferation (GO:0001937) | 4.79063362 |
41 | tooth mineralization (GO:0034505) | 4.69668447 |
42 | triglyceride biosynthetic process (GO:0019432) | 4.59927411 |
43 | phagocytosis, recognition (GO:0006910) | 4.56060160 |
44 | regulation of p38MAPK cascade (GO:1900744) | 4.55337904 |
45 | nucleoside transport (GO:0015858) | 4.54841127 |
46 | folic acid transport (GO:0015884) | 4.54650018 |
47 | * oligosaccharide biosynthetic process (GO:0009312) | 4.46312731 |
48 | GDP-mannose metabolic process (GO:0019673) | 4.41800613 |
49 | acylglycerol biosynthetic process (GO:0046463) | 4.41264438 |
50 | neutral lipid biosynthetic process (GO:0046460) | 4.41264438 |
51 | regulation of apoptotic cell clearance (GO:2000425) | 4.40099541 |
52 | carnitine transmembrane transport (GO:1902603) | 4.39580823 |
53 | response to phenylpropanoid (GO:0080184) | 4.37931003 |
54 | O-glycan processing (GO:0016266) | 4.34658737 |
55 | coenzyme A biosynthetic process (GO:0015937) | 4.31843266 |
56 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.27070090 |
57 | regulation of triglyceride biosynthetic process (GO:0010866) | 4.20365958 |
58 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.16593709 |
59 | response to host immune response (GO:0052572) | 4.16593709 |
60 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 4.08810901 |
61 | positive regulation of triglyceride metabolic process (GO:0090208) | 4.07407368 |
62 | Golgi transport vesicle coating (GO:0048200) | 4.06827418 |
63 | COPI coating of Golgi vesicle (GO:0048205) | 4.06827418 |
64 | regulation of triglyceride metabolic process (GO:0090207) | 4.05348487 |
65 | tricarboxylic acid metabolic process (GO:0072350) | 4.04187161 |
66 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.04005637 |
67 | growth hormone receptor signaling pathway (GO:0060396) | 4.02571393 |
68 | long-chain fatty acid transport (GO:0015909) | 4.01678638 |
69 | amino-acid betaine transport (GO:0015838) | 4.01637904 |
70 | carnitine transport (GO:0015879) | 4.01637904 |
71 | lipid storage (GO:0019915) | 3.93775276 |
72 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 3.93059688 |
73 | positive regulation of macrophage cytokine production (GO:0060907) | 3.88696151 |
74 | low-density lipoprotein particle clearance (GO:0034383) | 3.88367379 |
75 | negative regulation of lipid catabolic process (GO:0050995) | 3.82752133 |
76 | glutathione biosynthetic process (GO:0006750) | 3.82397789 |
77 | negative regulation of epithelial cell differentiation (GO:0030857) | 3.80033133 |
78 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.78296549 |
79 | copper ion transport (GO:0006825) | 3.70472127 |
80 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.70403493 |
81 | transcytosis (GO:0045056) | 3.70047155 |
82 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.69987433 |
83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.69936324 |
84 | response to host (GO:0075136) | 3.69936324 |
85 | response to host defenses (GO:0052200) | 3.69936324 |
86 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.67314261 |
87 | fatty acid transport (GO:0015908) | 3.67292344 |
88 | zinc ion transport (GO:0006829) | 3.64310842 |
89 | regulation of vasculogenesis (GO:2001212) | 3.63751862 |
90 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.63629940 |
91 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.61509372 |
92 | positive regulation of lipid storage (GO:0010884) | 3.60378496 |
93 | pentose-phosphate shunt (GO:0006098) | 3.60280868 |
94 | regulation of penile erection (GO:0060405) | 3.59493470 |
95 | intracellular lipid transport (GO:0032365) | 3.54859043 |
96 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.54721482 |
97 | regulation of macrophage cytokine production (GO:0010935) | 3.49291979 |
98 | acyl-CoA metabolic process (GO:0006637) | 3.48262896 |
99 | thioester metabolic process (GO:0035383) | 3.48262896 |
100 | negative regulation of fatty acid transport (GO:2000192) | 3.47778592 |
101 | regulation of execution phase of apoptosis (GO:1900117) | 3.47537107 |
102 | regulation of endothelial cell differentiation (GO:0045601) | 3.45600847 |
103 | heme transport (GO:0015886) | 3.44334890 |
104 | regulation of triglyceride catabolic process (GO:0010896) | 3.40476091 |
105 | cellular response to growth hormone stimulus (GO:0071378) | 3.39784202 |
106 | type B pancreatic cell proliferation (GO:0044342) | 3.37919424 |
107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.37491424 |
108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.37491424 |
109 | sphingolipid catabolic process (GO:0030149) | 3.32093986 |
110 | purine nucleobase metabolic process (GO:0006144) | 3.31755802 |
111 | regulation of cholesterol storage (GO:0010885) | 3.29715129 |
112 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.29243830 |
113 | positive regulation of chemokine secretion (GO:0090197) | 3.28994566 |
114 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.28375214 |
115 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.28375214 |
116 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.28375214 |
117 | coenzyme A metabolic process (GO:0015936) | 3.26999207 |
118 | branched-chain amino acid metabolic process (GO:0009081) | 3.26796832 |
119 | positive regulation of histone deacetylation (GO:0031065) | 3.26004425 |
120 | mitochondrion distribution (GO:0048311) | 3.25882944 |
121 | triglyceride catabolic process (GO:0019433) | 3.23905433 |
122 | temperature homeostasis (GO:0001659) | 3.23394510 |
123 | valine metabolic process (GO:0006573) | 3.22349882 |
124 | iron coordination entity transport (GO:1901678) | 3.21714210 |
125 | cellular response to vitamin D (GO:0071305) | 3.21052166 |
126 | triglyceride metabolic process (GO:0006641) | 3.20631453 |
127 | NADPH regeneration (GO:0006740) | 3.19475475 |
128 | angiogenesis involved in wound healing (GO:0060055) | 3.18420892 |
129 | branched-chain amino acid catabolic process (GO:0009083) | 3.16951262 |
130 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.14251564 |
131 | regulation of fatty acid oxidation (GO:0046320) | 3.13210047 |
132 | sialylation (GO:0097503) | 3.12236524 |
133 | steroid catabolic process (GO:0006706) | 3.07594911 |
134 | proximal/distal pattern formation (GO:0009954) | 3.06105736 |
135 | positive regulation of tissue remodeling (GO:0034105) | 3.05197640 |
136 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.04727114 |
137 | acylglycerol metabolic process (GO:0006639) | 3.02633884 |
138 | regulation of lipid storage (GO:0010883) | 3.02107514 |
139 | urate metabolic process (GO:0046415) | 3.01781162 |
140 | neutral lipid metabolic process (GO:0006638) | 2.98576518 |
141 | acylglycerol catabolic process (GO:0046464) | 2.97487075 |
142 | neutral lipid catabolic process (GO:0046461) | 2.97487075 |
143 | membrane lipid catabolic process (GO:0046466) | 2.96132703 |
144 | regulation of chemokine secretion (GO:0090196) | 2.94075231 |
145 | galactose metabolic process (GO:0006012) | 2.89105131 |
146 | negative regulation of cell fate commitment (GO:0010454) | 2.88000328 |
147 | folic acid metabolic process (GO:0046655) | 2.87845752 |
148 | short-chain fatty acid metabolic process (GO:0046459) | 2.80095821 |
149 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.77585938 |
150 | acrosome assembly (GO:0001675) | 2.73582774 |
151 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.69986419 |
152 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.66855253 |
153 | peptide biosynthetic process (GO:0043043) | 2.59052390 |
154 | negative regulation of leukocyte migration (GO:0002686) | 2.56068200 |
155 | detection of molecule of bacterial origin (GO:0032490) | 2.53001492 |
156 | ether lipid metabolic process (GO:0046485) | 2.51851185 |
157 | digestive system process (GO:0022600) | 2.47095250 |
158 | one-carbon metabolic process (GO:0006730) | 2.46758507 |
159 | positive regulation of macrophage activation (GO:0043032) | 2.44498781 |
160 | citrulline biosynthetic process (GO:0019240) | 2.44473872 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 7.15225945 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.09043529 |
3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 5.18572319 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.38181679 |
5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 4.20126032 |
6 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.36921683 |
7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.34691810 |
8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.34332475 |
9 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.24299216 |
10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.06252540 |
11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.05445456 |
12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.82768227 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.75678185 |
14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.50859799 |
15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.47171632 |
16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.38705923 |
17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.27986636 |
18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18014120 |
19 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14113455 |
20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.08539195 |
21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08181146 |
22 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.07331299 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00616529 |
24 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.00585845 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98018206 |
26 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.85300900 |
27 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.83102620 |
28 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.81869319 |
29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.80216521 |
30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.75214137 |
31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.75130859 |
32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.70844532 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.65189214 |
34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.62032583 |
35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.61294237 |
36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59020950 |
37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54810888 |
38 | RXR_22108803_ChIP-Seq_LS180_Human | 1.52723423 |
39 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.49021362 |
40 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44832919 |
41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44784269 |
42 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43728592 |
43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43344945 |
44 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.42717744 |
45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40782804 |
46 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32551748 |
47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32015234 |
48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.31723639 |
49 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.30875527 |
50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30146517 |
51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29793630 |
52 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29668603 |
53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24671145 |
54 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.24295468 |
55 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.24281039 |
56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23608350 |
57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22209865 |
58 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.20596160 |
59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.20298394 |
60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20227524 |
61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.18116672 |
62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17223366 |
63 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17142420 |
64 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.16878147 |
65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15926922 |
66 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15814544 |
67 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15814544 |
68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09277668 |
69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05944276 |
70 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05817981 |
71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05771138 |
72 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.05659230 |
73 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.05525424 |
74 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04971582 |
75 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04777735 |
76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03520660 |
77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02255624 |
78 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.02011485 |
79 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01236443 |
80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01100971 |
81 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99742277 |
82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99195563 |
83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99187372 |
84 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97589740 |
85 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.97429165 |
86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97392851 |
87 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96856408 |
88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96418997 |
89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95893632 |
90 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95863765 |
91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94573795 |
92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93895861 |
93 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93350585 |
94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88443784 |
95 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88354447 |
96 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88118643 |
97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87925499 |
98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86702759 |
99 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86683275 |
100 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86633562 |
101 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85876892 |
102 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.85866397 |
103 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.85676090 |
104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.85570563 |
105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84723747 |
106 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.84546195 |
107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84510954 |
108 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.84282319 |
109 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.84046552 |
110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83762294 |
111 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.83708194 |
112 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83684664 |
113 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.83449125 |
114 | CJUN_26792858_Chip-Seq_BT549_Human | 0.83348603 |
115 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83197468 |
116 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.83124166 |
117 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82686646 |
118 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82504144 |
119 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.80269077 |
120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80093961 |
121 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.80059459 |
122 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.79899467 |
123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79849654 |
124 | KDM2B_26808549_Chip-Seq_K562_Human | 0.79559562 |
125 | NFYA_21822215_ChIP-Seq_K562_Human | 0.79430805 |
126 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79382903 |
127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78414945 |
128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78232572 |
129 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.78208653 |
130 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.78129089 |
131 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.77937373 |
132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77575930 |
133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77017594 |
134 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.76669248 |
135 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76622386 |
136 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76162594 |
137 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.76109549 |
138 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.75126866 |
139 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74890256 |
140 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.74837477 |
141 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74325228 |
142 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.74183426 |
143 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.73615044 |
144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73516806 |
145 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.72980154 |
146 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.72890108 |
147 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72569959 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 4.94303404 |
2 | MP0005083_abnormal_biliary_tract | 3.80337806 |
3 | MP0002254_reproductive_system_inflammat | 3.56816360 |
4 | MP0003303_peritoneal_inflammation | 3.29470619 |
5 | MP0003300_gastrointestinal_ulcer | 3.27164922 |
6 | MP0004130_abnormal_muscle_cell | 2.99980192 |
7 | * MP0000627_abnormal_mammary_gland | 2.91303919 |
8 | MP0004019_abnormal_vitamin_homeostasis | 2.84318839 |
9 | MP0001873_stomach_inflammation | 2.57379216 |
10 | MP0004147_increased_porphyrin_level | 2.42289670 |
11 | MP0003705_abnormal_hypodermis_morpholog | 2.39248077 |
12 | MP0003136_yellow_coat_color | 2.36400282 |
13 | MP0003011_delayed_dark_adaptation | 2.35693376 |
14 | MP0002796_impaired_skin_barrier | 2.02851715 |
15 | MP0005360_urolithiasis | 2.02806064 |
16 | MP0005085_abnormal_gallbladder_physiolo | 2.01032024 |
17 | * MP0001881_abnormal_mammary_gland | 11.5973412 |
18 | MP0004264_abnormal_extraembryonic_tissu | 1.93030074 |
19 | MP0005666_abnormal_adipose_tissue | 1.92009270 |
20 | MP0003718_maternal_effect | 1.87333999 |
21 | MP0005670_abnormal_white_adipose | 1.82705126 |
22 | MP0004043_abnormal_pH_regulation | 1.71326227 |
23 | MP0005645_abnormal_hypothalamus_physiol | 1.63267534 |
24 | MP0005410_abnormal_fertilization | 1.59181500 |
25 | MP0002118_abnormal_lipid_homeostasis | 1.53662193 |
26 | MP0001666_abnormal_nutrient_absorption | 1.51716127 |
27 | MP0010329_abnormal_lipoprotein_level | 1.42344565 |
28 | MP0005375_adipose_tissue_phenotype | 1.40003435 |
29 | MP0004185_abnormal_adipocyte_glucose | 1.38535104 |
30 | MP0005395_other_phenotype | 1.34624019 |
31 | MP0001664_abnormal_digestion | 1.31488787 |
32 | MP0002098_abnormal_vibrissa_morphology | 1.30906504 |
33 | MP0008438_abnormal_cutaneous_collagen | 1.27065548 |
34 | MP0004272_abnormal_basement_membrane | 1.26216927 |
35 | MP0008004_abnormal_stomach_pH | 1.23015828 |
36 | MP0000678_abnormal_parathyroid_gland | 1.22398310 |
37 | MP0002139_abnormal_hepatobiliary_system | 1.20309042 |
38 | MP0002009_preneoplasia | 1.10053674 |
39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09150895 |
40 | MP0003566_abnormal_cell_adhesion | 1.07882495 |
41 | MP0001849_ear_inflammation | 1.07222729 |
42 | MP0005501_abnormal_skin_physiology | 1.05871025 |
43 | MP0000377_abnormal_hair_follicle | 1.05255032 |
44 | MP0009764_decreased_sensitivity_to | 1.03201432 |
45 | MP0002971_abnormal_brown_adipose | 1.00960669 |
46 | MP0009384_cardiac_valve_regurgitation | 0.96708435 |
47 | MP0001663_abnormal_digestive_system | 0.96161253 |
48 | MP0010352_gastrointestinal_tract_polyps | 0.94965419 |
49 | MP0002168_other_aberrant_phenotype | 0.94215847 |
50 | MP0010678_abnormal_skin_adnexa | 0.92901966 |
51 | MP0005076_abnormal_cell_differentiation | 0.92531374 |
52 | MP0005332_abnormal_amino_acid | 0.90798534 |
53 | MP0005334_abnormal_fat_pad | 0.90131803 |
54 | MP0000639_abnormal_adrenal_gland | 0.89236759 |
55 | MP0000490_abnormal_crypts_of | 0.89234614 |
56 | MP0000750_abnormal_muscle_regeneration | 0.89210318 |
57 | MP0005448_abnormal_energy_balance | 0.88715308 |
58 | MP0003045_fibrosis | 0.88095508 |
59 | MP0000609_abnormal_liver_physiology | 0.87964838 |
60 | MP0003936_abnormal_reproductive_system | 0.87481842 |
61 | MP0009278_abnormal_bone_marrow | 0.84458170 |
62 | MP0002970_abnormal_white_adipose | 0.83679756 |
63 | MP0009765_abnormal_xenobiotic_induced | 0.83121284 |
64 | MP0000013_abnormal_adipose_tissue | 0.83110709 |
65 | MP0005275_abnormal_skin_tensile | 0.82996020 |
66 | MP0003448_altered_tumor_morphology | 0.82708483 |
67 | MP0001879_abnormal_lymphatic_vessel | 0.81840280 |
68 | MP0008260_abnormal_autophagy | 0.81549550 |
69 | MP0005171_absent_coat_pigmentation | 0.81478687 |
70 | MP0001958_emphysema | 0.80649423 |
71 | MP0008770_decreased_survivor_rate | 0.79321394 |
72 | MP0002396_abnormal_hematopoietic_system | 0.78081405 |
73 | MP0005636_abnormal_mineral_homeostasis | 0.76602582 |
74 | MP0003075_altered_response_to | 0.76548772 |
75 | MP0005365_abnormal_bile_salt | 0.75687492 |
76 | MP0003690_abnormal_glial_cell | 0.75445982 |
77 | MP0002896_abnormal_bone_mineralization | 0.75416817 |
78 | MP0005381_digestive/alimentary_phenotyp | 0.74939649 |
79 | MP0001984_abnormal_olfaction | 0.74759931 |
80 | MP0005535_abnormal_body_temperature | 0.74390724 |
81 | MP0001727_abnormal_embryo_implantation | 0.73443891 |
82 | MP0009643_abnormal_urine_homeostasis | 0.69700686 |
83 | MP0005220_abnormal_exocrine_pancreas | 0.67636712 |
84 | MP0000003_abnormal_adipose_tissue | 0.67605446 |
85 | MP0000613_abnormal_salivary_gland | 0.67444209 |
86 | MP0005023_abnormal_wound_healing | 0.67419569 |
87 | MP0005386_behavior/neurological_phenoty | 0.65628069 |
88 | MP0004924_abnormal_behavior | 0.65628069 |
89 | MP0004947_skin_inflammation | 0.64352387 |
90 | MP0002078_abnormal_glucose_homeostasis | 0.63560287 |
91 | MP0003172_abnormal_lysosome_physiology | 0.62226981 |
92 | MP0003656_abnormal_erythrocyte_physiolo | 0.61411267 |
93 | MP0003950_abnormal_plasma_membrane | 0.59927885 |
94 | MP0003453_abnormal_keratinocyte_physiol | 0.59903851 |
95 | MP0001216_abnormal_epidermal_layer | 0.59421461 |
96 | MP0005452_abnormal_adipose_tissue | 0.59275970 |
97 | MP0001851_eye_inflammation | 0.57917766 |
98 | MP0002282_abnormal_trachea_morphology | 0.57801806 |
99 | MP0005164_abnormal_response_to | 0.57660561 |
100 | MP0003959_abnormal_lean_body | 0.57472721 |
101 | MP0000858_altered_metastatic_potential | 0.56962200 |
102 | MP0003948_abnormal_gas_homeostasis | 0.54536019 |
103 | MP0001765_abnormal_ion_homeostasis | 0.54354582 |
104 | MP0002148_abnormal_hypersensitivity_rea | 0.54335722 |
105 | MP0005165_increased_susceptibility_to | 0.52796019 |
106 | MP0004858_abnormal_nervous_system | 0.52297925 |
107 | MP0006054_spinal_hemorrhage | 0.52281981 |
108 | MP0001177_atelectasis | 0.51600595 |
109 | MP0009379_abnormal_foot_pigmentation | 0.51320245 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.51071562 |
111 | MP0005408_hypopigmentation | 0.50017686 |
112 | MP0009763_increased_sensitivity_to | 0.48951233 |
113 | MP0002060_abnormal_skin_morphology | 0.48916238 |
114 | MP0003953_abnormal_hormone_level | 0.48770902 |
115 | MP0002332_abnormal_exercise_endurance | 0.47559474 |
116 | MP0009931_abnormal_skin_appearance | 0.46068866 |
117 | MP0000920_abnormal_myelination | 0.46048630 |
118 | MP0001533_abnormal_skeleton_physiology | 0.45231528 |
119 | MP0000759_abnormal_skeletal_muscle | 0.45101285 |
120 | MP0005385_cardiovascular_system_phenoty | 0.44178293 |
121 | MP0001544_abnormal_cardiovascular_syste | 0.44178293 |
122 | MP0009642_abnormal_blood_homeostasis | 0.41966495 |
123 | MP0002135_abnormal_kidney_morphology | 0.41738624 |
124 | MP0005058_abnormal_lysosome_morphology | 0.41275990 |
125 | MP0003195_calcinosis | 0.40346679 |
126 | MP0002133_abnormal_respiratory_system | 0.40273087 |
127 | MP0005388_respiratory_system_phenotype | 0.40273087 |
128 | MP0010771_integument_phenotype | 0.39631097 |
129 | MP0009785_altered_susceptibility_to | 0.38189301 |
130 | MP0000371_diluted_coat_color | 0.37987222 |
131 | MP0001756_abnormal_urination | 0.35256271 |
132 | MP0004782_abnormal_surfactant_physiolog | 0.34176196 |
133 | MP0008789_abnormal_olfactory_epithelium | 0.32230211 |
134 | MP0008874_decreased_physiological_sensi | 0.32222345 |
135 | MP0000343_altered_response_to | 0.29529850 |
136 | MP0001853_heart_inflammation | 0.29296432 |
137 | MP0002419_abnormal_innate_immunity | 0.29107813 |
138 | MP0001542_abnormal_bone_strength | 0.28522920 |
139 | MP0005499_abnormal_olfactory_system | 0.27247018 |
140 | MP0005394_taste/olfaction_phenotype | 0.27247018 |
141 | MP0001764_abnormal_homeostasis | 0.26381096 |
142 | MP0002089_abnormal_postnatal_growth/wei | 0.26222392 |
143 | MP0002693_abnormal_pancreas_physiology | 0.24861829 |
144 | MP0000537_abnormal_urethra_morphology | 0.24584485 |
145 | MP0005451_abnormal_body_composition | 0.23745351 |
146 | MP0003638_abnormal_response/metabolism_ | 0.23739741 |
147 | MP0000598_abnormal_liver_morphology | 0.22466570 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperactive renin-angiotensin system (HP:0000841) | 6.82754406 |
2 | Decreased circulating renin level (HP:0003351) | 6.66287644 |
3 | Abnormality of purine metabolism (HP:0004352) | 6.30385523 |
4 | Gout (HP:0001997) | 5.61953506 |
5 | Axonal loss (HP:0003447) | 5.38910656 |
6 | Amelogenesis imperfecta (HP:0000705) | 5.33667701 |
7 | Congenital ichthyosiform erythroderma (HP:0007431) | 5.08856431 |
8 | Thin bony cortex (HP:0002753) | 4.53841042 |
9 | Hypokalemic alkalosis (HP:0001949) | 4.45643414 |
10 | Epidermoid cyst (HP:0200040) | 4.33714094 |
11 | Overgrowth (HP:0001548) | 3.96467521 |
12 | Hyperkalemia (HP:0002153) | 3.94106545 |
13 | Hyperlipoproteinemia (HP:0010980) | 3.93744426 |
14 | Abnormality of nucleobase metabolism (HP:0010932) | 3.83827584 |
15 | Hydronephrosis (HP:0000126) | 3.83346208 |
16 | Pili torti (HP:0003777) | 3.81267223 |
17 | Myocardial infarction (HP:0001658) | 3.79708254 |
18 | Chronic bronchitis (HP:0004469) | 3.78467718 |
19 | Nephritis (HP:0000123) | 3.75563360 |
20 | Hyperaldosteronism (HP:0000859) | 3.68546660 |
21 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.60415194 |
22 | Tubulointerstitial nephritis (HP:0001970) | 3.60134668 |
23 | Right ventricular cardiomyopathy (HP:0011663) | 3.57512807 |
24 | Stridor (HP:0010307) | 3.47802475 |
25 | Skin nodule (HP:0200036) | 3.42293201 |
26 | Enlarged epiphyses (HP:0010580) | 3.40731204 |
27 | Metaphyseal dysplasia (HP:0100255) | 3.36091975 |
28 | Protuberant abdomen (HP:0001538) | 3.35615543 |
29 | Abnormality of renal excretion (HP:0011036) | 3.31356919 |
30 | Curly hair (HP:0002212) | 3.29490524 |
31 | Ectropion (HP:0000656) | 3.27140544 |
32 | Subcapsular cataract (HP:0000523) | 3.26243044 |
33 | Hypotension (HP:0002615) | 3.18813840 |
34 | Aortic aneurysm (HP:0004942) | 3.14140695 |
35 | Neurodegeneration (HP:0002180) | 3.11318897 |
36 | Abnormality of renin-angiotensin system (HP:0000847) | 3.08644111 |
37 | Xanthomatosis (HP:0000991) | 3.07324418 |
38 | Metaphyseal irregularity (HP:0003025) | 3.04978814 |
39 | Hyponatremia (HP:0002902) | 3.03039212 |
40 | Tubulointerstitial fibrosis (HP:0005576) | 3.01839521 |
41 | Glomerulosclerosis (HP:0000096) | 3.00680858 |
42 | Abnormal tarsal ossification (HP:0008369) | 2.88464972 |
43 | Abnormality of renal resorption (HP:0011038) | 2.87300559 |
44 | Turricephaly (HP:0000262) | 2.84616324 |
45 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.81643722 |
46 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.81620634 |
47 | Cerebral aneurysm (HP:0004944) | 2.79782043 |
48 | Abnormality of chloride homeostasis (HP:0011422) | 2.78529701 |
49 | Flat acetabular roof (HP:0003180) | 2.75473717 |
50 | Bone cyst (HP:0012062) | 2.71118200 |
51 | Abnormal auditory evoked potentials (HP:0006958) | 2.69258487 |
52 | Hyperuricemia (HP:0002149) | 2.69171129 |
53 | Increased purine levels (HP:0004368) | 2.69171129 |
54 | Nausea (HP:0002018) | 2.69167322 |
55 | Delayed epiphyseal ossification (HP:0002663) | 2.57488812 |
56 | Epiphyseal dysplasia (HP:0002656) | 2.57284926 |
57 | Ketoacidosis (HP:0001993) | 2.52146267 |
58 | Aortic dissection (HP:0002647) | 2.50435355 |
59 | Renal salt wasting (HP:0000127) | 2.49377305 |
60 | Abnormality of sodium homeostasis (HP:0010931) | 2.46233249 |
61 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.46112852 |
62 | Hypoplasia of the iris (HP:0007676) | 2.43716309 |
63 | Atrophic scars (HP:0001075) | 2.41223929 |
64 | Premature skin wrinkling (HP:0100678) | 2.40679747 |
65 | Loss of speech (HP:0002371) | 2.38167349 |
66 | Vacuolated lymphocytes (HP:0001922) | 2.38014006 |
67 | Abdominal distention (HP:0003270) | 2.37770853 |
68 | Enlarged penis (HP:0000040) | 2.37494825 |
69 | Hyperglycinemia (HP:0002154) | 2.36493285 |
70 | Nephrolithiasis (HP:0000787) | 2.34905337 |
71 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31504067 |
72 | Hyperglycinuria (HP:0003108) | 2.31497196 |
73 | Intrahepatic cholestasis (HP:0001406) | 2.30236691 |
74 | Adrenal overactivity (HP:0002717) | 2.28859503 |
75 | Tubular atrophy (HP:0000092) | 2.28359433 |
76 | Abnormal hair laboratory examination (HP:0003328) | 2.28297592 |
77 | Rickets (HP:0002748) | 2.24110119 |
78 | Aneurysm (HP:0002617) | 2.23590849 |
79 | Widely patent fontanelles and sutures (HP:0004492) | 2.20394464 |
80 | Alkalosis (HP:0001948) | 2.19418645 |
81 | Deep venous thrombosis (HP:0002625) | 2.19052349 |
82 | Hypoplasia of dental enamel (HP:0006297) | 2.17462588 |
83 | Hepatosplenomegaly (HP:0001433) | 2.15472040 |
84 | Polar cataract (HP:0010696) | 2.15016113 |
85 | Glomerulonephritis (HP:0000099) | 2.13423886 |
86 | Cortical dysplasia (HP:0002539) | 2.13130250 |
87 | Asymmetry of the thorax (HP:0001555) | 2.12049947 |
88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.10625316 |
89 | Wide cranial sutures (HP:0010537) | 2.10384162 |
90 | Increased serum ferritin (HP:0003281) | 2.09557813 |
91 | Abnormal epiphyseal ossification (HP:0010656) | 2.08727992 |
92 | Abnormality of vision evoked potentials (HP:0000649) | 2.07281052 |
93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07215245 |
94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07215245 |
95 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07215245 |
96 | Osteolytic defects of the hand bones (HP:0009699) | 2.06992894 |
97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06992894 |
98 | Buphthalmos (HP:0000557) | 2.06931930 |
99 | Hypercholesterolemia (HP:0003124) | 2.06691365 |
100 | Optic neuritis (HP:0100653) | 2.06583000 |
101 | Retrobulbar optic neuritis (HP:0100654) | 2.06583000 |
102 | Metabolic acidosis (HP:0001942) | 2.05144786 |
103 | Biliary tract neoplasm (HP:0100574) | 2.05019302 |
104 | Elevated alkaline phosphatase (HP:0003155) | 2.04112176 |
105 | Arterial tortuosity (HP:0005116) | 2.01735742 |
106 | Azoospermia (HP:0000027) | 2.01384839 |
107 | Abnormality of dental color (HP:0011073) | 2.01092119 |
108 | Abnormality of the anterior chamber (HP:0000593) | 2.00598773 |
109 | Abnormality of the periventricular white matter (HP:0002518) | 2.00584380 |
110 | Milia (HP:0001056) | 1.97500393 |
111 | Postnatal microcephaly (HP:0005484) | 1.97296339 |
112 | Premature loss of primary teeth (HP:0006323) | 1.93966212 |
113 | Ketosis (HP:0001946) | 1.92348530 |
114 | Orchitis (HP:0100796) | 1.92190192 |
115 | Hypophosphatemia (HP:0002148) | 1.91087320 |
116 | Hypokalemia (HP:0002900) | 1.90930882 |
117 | Abnormality of the costochondral junction (HP:0000919) | 1.90522806 |
118 | Poor eye contact (HP:0000817) | 1.90412919 |
119 | Dysostosis multiplex (HP:0000943) | 1.87972880 |
120 | Long toe (HP:0010511) | 1.87247724 |
121 | Increased cerebral lipofuscin (HP:0011813) | 1.86620843 |
122 | Tetraparesis (HP:0002273) | 1.85133138 |
123 | Asymmetric septal hypertrophy (HP:0001670) | 1.84361291 |
124 | Spastic tetraparesis (HP:0001285) | 1.83472491 |
125 | Peripheral hypomyelination (HP:0007182) | 1.83163930 |
126 | Vascular tortuosity (HP:0004948) | 1.82708604 |
127 | Abnormality of the dental pulp (HP:0006479) | 1.82581475 |
128 | Paraparesis (HP:0002385) | 1.82266403 |
129 | Conjunctival hamartoma (HP:0100780) | 1.82198512 |
130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81487207 |
131 | Pustule (HP:0200039) | 1.79474520 |
132 | Abnormality of glycine metabolism (HP:0010895) | 1.78501700 |
133 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.78501700 |
134 | Epiphyseal stippling (HP:0010655) | 1.76773004 |
135 | Pancreatitis (HP:0001733) | 1.76214400 |
136 | Autoamputation (HP:0001218) | 1.76162242 |
137 | Cortical visual impairment (HP:0100704) | 1.75976248 |
138 | Fatigue (HP:0012378) | 1.75807323 |
139 | Peripheral demyelination (HP:0011096) | 1.75569456 |
140 | Back pain (HP:0003418) | 1.75236722 |
141 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74799535 |
142 | Abnormality of iron homeostasis (HP:0011031) | 1.74432455 |
143 | Symptomatic seizures (HP:0011145) | 1.74152398 |
144 | Abnormality of the intrinsic pathway (HP:0010989) | 1.73330647 |
145 | Onycholysis (HP:0001806) | 1.73071103 |
146 | Striae distensae (HP:0001065) | 1.72952385 |
147 | Esophageal varix (HP:0002040) | 1.72264328 |
148 | Hyperparathyroidism (HP:0000843) | 1.70951609 |
149 | Cardiovascular calcification (HP:0011915) | 1.69790813 |
150 | Ankle contracture (HP:0006466) | 1.69683229 |
151 | Congenital glaucoma (HP:0001087) | 1.69631184 |
152 | Increased serum pyruvate (HP:0003542) | 1.68657130 |
153 | Abnormality of glycolysis (HP:0004366) | 1.68657130 |
154 | Vascular calcification (HP:0004934) | 1.68409545 |
155 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.67431926 |
156 | Primary adrenal insufficiency (HP:0008207) | 1.67266946 |
157 | Hemorrhage of the eye (HP:0011885) | 1.65633395 |
158 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.63941402 |
159 | Flat occiput (HP:0005469) | 1.63050019 |
160 | Opisthotonus (HP:0002179) | 1.63038623 |
161 | Systemic lupus erythematosus (HP:0002725) | 1.62839983 |
162 | Abnormality of the renal cortex (HP:0011035) | 1.61870075 |
163 | Genu varum (HP:0002970) | 1.60053394 |
164 | Reduced antithrombin III activity (HP:0001976) | 1.59985964 |
165 | Tubulointerstitial abnormality (HP:0001969) | 1.55471470 |
166 | Dehydration (HP:0001944) | 1.54864121 |
167 | Rough bone trabeculation (HP:0100670) | 1.50766049 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SIK1 | 6.02418000 |
2 | CAMK1D | 5.36831551 |
3 | PKN2 | 4.99729652 |
4 | CAMK1G | 4.24968349 |
5 | TRIB3 | 3.96855140 |
6 | EEF2K | 3.33939814 |
7 | ERN1 | 2.94978772 |
8 | ICK | 2.87649659 |
9 | NME2 | 2.86346920 |
10 | MAP2K6 | 2.76523419 |
11 | ARAF | 2.47507662 |
12 | PDK4 | 2.43059737 |
13 | PDK3 | 2.43059737 |
14 | TESK1 | 2.22380250 |
15 | PTK6 | 2.21951224 |
16 | MATK | 2.19316725 |
17 | PIK3CA | 2.17016822 |
18 | BCKDK | 1.96383100 |
19 | RIPK1 | 1.88202122 |
20 | PDK2 | 1.84074715 |
21 | EPHB1 | 1.79696506 |
22 | PDGFRB | 1.77627011 |
23 | MAPKAPK3 | 1.65459016 |
24 | TGFBR2 | 1.64897844 |
25 | MAP3K9 | 1.64244879 |
26 | BMPR2 | 1.61618521 |
27 | ZAP70 | 1.59647016 |
28 | IRAK1 | 1.54920566 |
29 | RET | 1.51080991 |
30 | EPHA3 | 1.48962972 |
31 | LATS1 | 1.40341004 |
32 | DAPK2 | 1.36942782 |
33 | PRKAA2 | 1.35469436 |
34 | MOS | 1.32782038 |
35 | STK39 | 1.26082559 |
36 | BRAF | 1.25449500 |
37 | MAP3K13 | 1.24170747 |
38 | MAP3K7 | 1.22475898 |
39 | LRRK2 | 1.19918300 |
40 | STK38 | 1.14342656 |
41 | WNK4 | 1.06688146 |
42 | FER | 1.04702357 |
43 | BMX | 1.02396252 |
44 | MAP3K6 | 1.02385352 |
45 | NLK | 1.02038033 |
46 | STK16 | 1.00549820 |
47 | TESK2 | 0.94562596 |
48 | DDR2 | 0.91096337 |
49 | RPS6KB2 | 0.90987910 |
50 | CHUK | 0.89123383 |
51 | RIPK4 | 0.89109095 |
52 | PINK1 | 0.85894524 |
53 | TRPM7 | 0.84004076 |
54 | CSNK2A2 | 0.76705962 |
55 | STK38L | 0.74147130 |
56 | CAMK2D | 0.70913931 |
57 | SGK3 | 0.70666563 |
58 | LIMK1 | 0.70578812 |
59 | IRAK4 | 0.70395741 |
60 | PTK2 | 0.68810796 |
61 | MAPK12 | 0.68739499 |
62 | FGFR4 | 0.65549578 |
63 | MAPKAPK5 | 0.64745031 |
64 | IRAK2 | 0.64713092 |
65 | MAP3K2 | 0.63386724 |
66 | FRK | 0.63206694 |
67 | CAMK2G | 0.62780443 |
68 | TBK1 | 0.61570208 |
69 | CAMK1 | 0.61483367 |
70 | PRKCD | 0.61351459 |
71 | PRKAA1 | 0.61240930 |
72 | JAK2 | 0.60135759 |
73 | GRK7 | 0.59702844 |
74 | GSK3A | 0.59153474 |
75 | CAMK2B | 0.56346893 |
76 | TAOK2 | 0.54981212 |
77 | MAP2K2 | 0.52554152 |
78 | PDGFRA | 0.52441394 |
79 | TYRO3 | 0.52288536 |
80 | FLT3 | 0.52065891 |
81 | TAOK1 | 0.51634984 |
82 | IGF1R | 0.50771033 |
83 | PRKCG | 0.50393013 |
84 | JAK1 | 0.50228159 |
85 | MYLK | 0.49610443 |
86 | MET | 0.49033626 |
87 | JAK3 | 0.47020780 |
88 | IKBKE | 0.45094431 |
89 | RPS6KA2 | 0.44504346 |
90 | TAOK3 | 0.43124685 |
91 | EIF2AK1 | 0.42848860 |
92 | SGK2 | 0.40584158 |
93 | MTOR | 0.40357578 |
94 | TYK2 | 0.39764816 |
95 | EPHA2 | 0.38464458 |
96 | PDPK1 | 0.38090268 |
97 | EIF2AK2 | 0.37793593 |
98 | CSF1R | 0.37418926 |
99 | TIE1 | 0.37269208 |
100 | ERBB2 | 0.37222310 |
101 | NEK6 | 0.36541507 |
102 | FGR | 0.36414350 |
103 | PRKD1 | 0.36412443 |
104 | CAMKK1 | 0.35677830 |
105 | CSNK1A1 | 0.35282790 |
106 | PDK1 | 0.34813718 |
107 | EGFR | 0.34055876 |
108 | TTN | 0.32900091 |
109 | KSR2 | 0.32587841 |
110 | PAK2 | 0.31922425 |
111 | MAPK11 | 0.31885538 |
112 | PAK4 | 0.31335816 |
113 | PTK2B | 0.29834902 |
114 | MAP2K1 | 0.29647898 |
115 | EIF2AK3 | 0.29280440 |
116 | DYRK2 | 0.29105322 |
117 | MAP3K3 | 0.25973234 |
118 | MAP3K1 | 0.25875181 |
119 | IRAK3 | 0.25545455 |
120 | LYN | 0.25499856 |
121 | DAPK3 | 0.25449515 |
122 | SRC | 0.25396980 |
123 | PRKCZ | 0.25083297 |
124 | RAF1 | 0.24804651 |
125 | LMTK2 | 0.24733906 |
126 | STK3 | 0.23518802 |
127 | NEK9 | 0.22780975 |
128 | FGFR3 | 0.21645651 |
129 | WNK1 | 0.21128508 |
130 | CDK6 | 0.20781483 |
131 | ILK | 0.20635184 |
132 | CDK9 | 0.20480348 |
133 | PIK3CG | 0.20392572 |
134 | RPS6KB1 | 0.20306521 |
135 | SGK223 | 0.20194019 |
136 | SGK494 | 0.20194019 |
137 | LATS2 | 0.19497438 |
138 | SCYL2 | 0.19312180 |
139 | PIM1 | 0.17640272 |
140 | GRK6 | 0.15857800 |
141 | FGFR1 | 0.13708483 |
142 | INSR | 0.12994128 |
143 | CSK | 0.12533483 |
144 | BTK | 0.10902166 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 9.48390423 |
2 | Caffeine metabolism_Homo sapiens_hsa00232 | 8.86161016 |
3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.91825572 |
4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.60251133 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.33311552 |
6 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.19548071 |
7 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.93581045 |
8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78896434 |
9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.67182644 |
10 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.54581518 |
11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.53968766 |
12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51961188 |
13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19810562 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.13189360 |
15 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12027590 |
16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07534282 |
17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04031830 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97092060 |
19 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96510659 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92313084 |
21 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89941418 |
22 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89430602 |
23 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87592353 |
24 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.84939920 |
25 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82862674 |
26 | Insulin resistance_Homo sapiens_hsa04931 | 0.82608093 |
27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77934050 |
28 | Protein export_Homo sapiens_hsa03060 | 0.77615740 |
29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73776392 |
30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73703939 |
31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72585167 |
32 | Peroxisome_Homo sapiens_hsa04146 | 0.72557646 |
33 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71037300 |
34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69199176 |
35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63634065 |
36 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62385022 |
37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61841602 |
38 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59528839 |
39 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57997985 |
40 | Amoebiasis_Homo sapiens_hsa05146 | 0.52505608 |
41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52215550 |
42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51677663 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49650314 |
44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49494333 |
45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49454930 |
46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46971909 |
47 | Bladder cancer_Homo sapiens_hsa05219 | 0.46768405 |
48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45432843 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44849376 |
50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44804032 |
51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44726460 |
52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42156459 |
53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41413121 |
54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41105273 |
55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41089288 |
56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40773966 |
57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40060927 |
58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39241009 |
59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39117074 |
60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38472058 |
61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37974923 |
62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36978303 |
63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.36440420 |
64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36322189 |
65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35652418 |
66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35399270 |
67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35271529 |
68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35125448 |
69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33824905 |
70 | Focal adhesion_Homo sapiens_hsa04510 | 0.33348678 |
71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33240134 |
72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32853563 |
73 | Hepatitis C_Homo sapiens_hsa05160 | 0.32753740 |
74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31814268 |
75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.30686722 |
76 | Mineral absorption_Homo sapiens_hsa04978 | 0.30098285 |
77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29902211 |
78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29601646 |
79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29413668 |
80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29022719 |
81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28415277 |
82 | Tight junction_Homo sapiens_hsa04530 | 0.28133955 |
83 | Lysosome_Homo sapiens_hsa04142 | 0.27546461 |
84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27200786 |
85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27103550 |
86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27027762 |
87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26766299 |
88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26745735 |
89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26719172 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.25964063 |
91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25865883 |
92 | Adherens junction_Homo sapiens_hsa04520 | 0.25202538 |
93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24254747 |
94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24253279 |
95 | Purine metabolism_Homo sapiens_hsa00230 | 0.24024752 |
96 | Bile secretion_Homo sapiens_hsa04976 | 0.23142919 |
97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.23104516 |
98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22341932 |
99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.21372206 |
100 | Pertussis_Homo sapiens_hsa05133 | 0.21248831 |
101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20685875 |
102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20503035 |
103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20488677 |
104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.19122199 |
105 | Phagosome_Homo sapiens_hsa04145 | 0.18852897 |
106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18510771 |
107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18103787 |
108 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.17682938 |
109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17324797 |
110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.16017290 |
111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.15341401 |
112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.14605845 |
113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.14134469 |
114 | Salivary secretion_Homo sapiens_hsa04970 | 0.12589708 |
115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.12530718 |
116 | Tuberculosis_Homo sapiens_hsa05152 | 0.12173986 |
117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12048759 |
118 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.11539085 |
119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.10297131 |
120 | Malaria_Homo sapiens_hsa05144 | 0.09717270 |
121 | Hepatitis B_Homo sapiens_hsa05161 | 0.09584771 |
122 | Renin secretion_Homo sapiens_hsa04924 | 0.09189653 |
123 | Legionellosis_Homo sapiens_hsa05134 | 0.08788061 |
124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.06851953 |
125 | Salmonella infection_Homo sapiens_hsa05132 | 0.06692616 |
126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.05570511 |
127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03709459 |
128 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.02659414 |
129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02463487 |
130 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.02395572 |
131 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.02010594 |
132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00048699 |
133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0517698 |
134 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0376228 |
135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | -0.0332161 |
136 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | -0.0187687 |
137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | -0.0149819 |
138 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0130369 |